Human PRKAG2 cardiomyopathy is now recognized to be highly heterogeneous, variably penetrant, and generally milder than initially reported, an observation typical of how our understanding of monogenic disorders evolves. The gene discussed is PRKAG2; the disease is cardiomyopathy.